FDA advisory group rejects Covid boosters for most, limits to high-risk groups
A Food and Drug Administration advisory panel overwhelmingly voted Friday against giving Pfizer-BioNTech’s Covid-19 booster
A Food and Drug Administration advisory panel overwhelmingly voted Friday against giving Pfizer-BioNTech’s Covid-19 booster
WASHINGTON — An influential federal advisory panel overwhelmingly rejected a plan Friday to give Pfizer
Credit: KPBS Above: An expecting mother gets an ultrasound in this undated photo from 2015.
“It seems to me they just don’t care. We’re clearly not a high priority.” HUNTERSVILLE,